Radboudumc and partners Radboudumc and Eindhoven University of Technology join forces in BIOTRIP

1 July 2021

Radboudumc and Eindhoven University of Technology present: BIOTRIP. This independent biotech incubator aims to ensure human health through cutting edge biotech. BIOTRIP is a unique platform that brings together medical scientists and entrepreneurial biomedical engineers to work with biotech entrepreneurs. They develop, commercialize and make available vaccines and immunotherapies to patients with a variety of diseases.

Read more (in Dutch)

Related news items


Radboudumc Investment Day keeps growing

11 October 2024

Scientists, entrepreneurs and investors from the life sciences & health sector came together to exchange knowledge, network and talk about new collaborations.

read more

Third Radboudumc Investment Day again well-attended

16 October 2023

On October 12, the Radboudumc Investment Day took place for the third time. Scientists, entrepreneurs and investors from the life sciences & health sector came together in the Radboudumc Experience Center to exchange knowledge, network and talk about new collaborations.

read more

Funding for Simmunext New therapy for cancer treatment

11 August 2023

An investment from the Gelderland Early Stage Funding Fund (VFF Gelderland) will allow Radboudumc spin-off Simmunext Biotherapeutics BV to continue developing a new treatment for cancer.

read more

Boosting the startup ecosystem in Nijmegen!

22 June 2023

TechleapNL, Radboud university, Radboudumc and the municipality of Nijmegen hosted a successful event where innovative health and hightech startups shared their view on the challenges and opportunities for the local startup ecosystem.

read more

BIOTRIP vision for biotech incubator

9 November 2021 BIOTRIP, the biotech incubator, presents its vision. read more